Literature DB >> 8621784

Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27KIP1.

J Chen1, T Willingham, M Shuford, P D Nisen.   

Abstract

To investigate how overexpression of p27KIP1, a downstream effector of TGF-beta and a universal cyclin-dependent kinase (CDK) inhibitor could influence the malignant phenotype of malignant human brain tumor cells, an adenovirus vector system was used to transfer the human p27KIP1 gene (Adp27KIP1) into the human astrocytoma cell line, U-373MG. Inhibition of CDK activity in Adp27KIP1-infected cells was indicated by inhibition of [3H]thymidine incorporation, an increase in cell doubling time and by cell cycle arrest in G1. Notably, ectopic overexpression of p27KIP1 was associated with a marked decrease in the accumulation of aneuploid cells. Diminished malignant potential of Adp27KIP1-infected cells was manifested by the loss of anchorage-independent growth in soft agar and by the inability to induce tumorgenesis in a xenograft model. These studies suggest that p27KIP1 is a tumor suppressor gene and supports the use of Adp27KIP1 for gene therapy of human brain tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621784      PMCID: PMC507269          DOI: 10.1172/JCI118631

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 2.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells.

Authors:  L Hartwell
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

3.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

4.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

5.  Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor.

Authors:  N E Kohl; S D Mosser; S J deSolms; E A Giuliani; D L Pompliano; S L Graham; R L Smith; E M Scolnick; A Oliff; J B Gibbs
Journal:  Science       Date:  1993-06-25       Impact factor: 47.728

6.  Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

7.  Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism.

Authors:  A M Gómez-Foix; W S Coats; S Baqué; T Alam; R D Gerard; C B Newgard
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

8.  Antigen-dependent proliferation of cloned continuous lines of H-2-restricted influenza virus-specific cytotoxic T lymphocytes.

Authors:  M E Andrew; T J Braciale
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

9.  Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.

Authors:  P Carder; A H Wyllie; C A Purdie; R G Morris; S White; J Piris; C C Bird
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

10.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

View more
  18 in total

1.  Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.

Authors:  L Jin; X Qian; E Kulig; N Sanno; B W Scheithauer; K Kovacs; W F Young; R V Lloyd
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 2.  Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.

Authors:  L Pignataro; G Sambataro; D Pagani; G Pruneri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

3.  Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer.

Authors:  Annette Schmider-Ross; Olaf Pirsig; Elisabeth Gottschalk; Carsten Denkert; Werner Lichtenegger; Angela Reles
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-19       Impact factor: 4.553

4.  Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.

Authors:  Hong Wang; XiaoHua Jiang; Fan Yang; Gary B Chapman; William Durante; Nicholas E S Sibinga; Andrew I Schafer
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

5.  Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins.

Authors:  R P Wersto; E R Rosenthal; P K Seth; N T Eissa; R E Donahue
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

6.  Aberrant p27kip1 expression in endocrine and other tumors.

Authors:  R V Lloyd; L Jin; X Qian; E Kulig
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 7.  Delivery of cell cycle genes to block astrocytoma growth.

Authors:  J Fueyo; C Gomez-Manzano; T J Liu; W K Yung
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

8.  Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.

Authors:  D Chen; K Krasinski; A Sylvester; J Chen; P D Nisen; V Andrés
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

9.  High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.

Authors:  Dana Ungermannova; Junglim Lee; Gan Zhang; H Garry Dallmann; Charles S McHenry; Xuedong Liu
Journal:  J Biomol Screen       Date:  2013-04-15

10.  Growth Factors.

Authors:  Ricardo V. Lloyd
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.